Literature DB >> 17449641

Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway.

Tadaatsu Imaizumi1, Hidemi Yoshida, Nozomu Nishi, Hiroshi Sashinami, Takanori Nakamura, Mitsuomi Hirashima, Chikara Ohyama, Ken Itoh, Kei Satoh.   

Abstract

Galectin-9 is a member of the galectin family, which induces various biological reactions such as chemotaxis of eosinophils and apoptosis of T cells. We previously reported that polyinosinic-polycytidylic acid (poly IC), an authentic double-stranded RNA (dsRNA), induces the expression of galectin-9 in human umbilical vein endothelial cells (HUVECs). In the present study, we addressed the possible involvement of two potential receptors for dsRNA, Toll-like receptor (TLR) 3 and retinoic acid-inducible gene-I (RIG-I), in the expression of galectin-9 in HUVECs. Poly IC-induced galectin-9 expression was almost completely suppressed by RNA interference (RNAi) against TLR3, but not against RIG-I. LY294002, an inhibitor of phosphatidylinositol 3-kinase (PI3K), inhibited the induction of galectin-9 by poly IC. RNAi against interferon regulatory factor 3 (IRF3) also inhibited poly IC-induced galectin-9 expression. We conclude that TLR3, PI3K, and IRF3 are involved in the poly IC-induced galectin-9 expression in HUVECs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449641     DOI: 10.1093/glycob/cwm045

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  15 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.

Authors:  Shokrollah Elahi; Toshiro Niki; Mitsuomi Hirashima; Helen Horton
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

Review 3.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

4.  Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

Authors:  Andrew J Steelman; Roger Smith; C Jane Welsh; Jianrong Li
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

5.  Galectin-9 binds to O-glycans on protein disulfide isomerase.

Authors:  Katrin Schaefer; Nicholas E Webb; Mabel Pang; Jenny E Hernandez-Davies; Katharine P Lee; Pascual Gonzalez; Martin V Douglass; Benhur Lee; Linda G Baum
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

6.  Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3.

Authors:  Saydul Alam; Hongling Li; Andriana Margariti; Daniel Martin; Anna Zampetaki; Ouassila Habi; Gillian Cockerill; Yanhua Hu; Qingbo Xu; Lingfang Zeng
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

7.  Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.

Authors:  Omai B Garner; Tatyana Yun; Olivier Pernet; Hector C Aguilar; Arnold Park; Thomas A Bowden; Alexander N Freiberg; Benhur Lee; Linda G Baum
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

8.  dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.

Authors:  Giuseppina Farina; Michael York; Cindy Collins; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

9.  Astrocyte galectin-9 potentiates microglial TNF secretion.

Authors:  Andrew J Steelman; Jianrong Li
Journal:  J Neuroinflammation       Date:  2014-08-27       Impact factor: 8.322

10.  Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortality.

Authors:  Sven Martin Jørgensen; Sergey Afanasyev; Aleksei Krasnov
Journal:  BMC Genomics       Date:  2008-04-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.